Discover the differences between capital and regular dividends, their tax implications, and what they indicate about a ...
LEXINGTON, Mass., June 09, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a ...
Europa Metals Ltd, (‘Europa’ or the ‘Company’) advises that it will hold its postponed Annual General Meeting of its Shareholders at 11 ...
Keros Therapeutics plans to return $375 million to stockholders after a strategic review, while advancing its drug development efforts. Keros Therapeutics, Inc. has completed its review of strategic ...
DENVER--(BUSINESS WIRE)--Civitas Resources, Inc. (NYSE: CIVI) (“Civitas” or the “Company”) today announced that its Board of Directors has authorized reinstating a capital allocation strategy ...
AUSTIN, Texas, May 8, 2025 /PRNewswire/ -- ADAR1 Capital Management, LLC (together with its affiliates, "ADAR1"), the largest stockholder of Keros Therapeutics (Nasdaq: KROS) ("Keros" or the "Company" ...
Nuveen AMT-Free Quality Muni Inc offers tax-free muni bond income, appealing for high marginal tax rate investors, but half its distribution is return of capital, not true income. Leverage boosts ...
We believe much of the Company’s inability to provide stockholders with a return on their investment is the result of severely misaligned compensation incentives for senior management, speculative ...
What are the early trends we should look for to identify a stock that could multiply in value over the long term?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback